checkAd

     322  0 Kommentare DBV Technologies S.A. Announces Proposed Global Offering

    DBV Technologies S.A. Announces Proposed Global Offering

    Bagneux, France - October 20, 2014 - DBV Technologies (Euronext: DBV - ISIN: FR0010417345), a clinical-stage specialty biopharmaceutical company announced today that it intends to offer and sell, subject to market and other conditions, up to 2,673,641 of its ordinary shares in a global offering, which is comprised of an offer of ordinary shares in the form of American Depositary Shares, or ADSs, in the United States, Canada and countries outside of France in an underwritten public offering through U.S. underwriters and an offer of ordinary shares in France and countries outside of the United States and Canada in a concurrent registered private placement through international underwriters.  DBV intends to grant the U.S. underwriters a 30-day option to purchase additional ordinary shares in the form of ADSs in connection with the U.S. offering and the international underwriters a 30-day option to purchase up to additional ordinary shares in connection with the international registered private placement, up to a maximum of 3,074,686 ordinary shares to be sold in the global offering.  The closing of the U.S. offering and the international registered private placement will be conditioned on each other.  

    Each of the ADSs offered in the U.S. offering represents the right to receive one-half of one ordinary share. Application has been made for listing of the ADSs on the Nasdaq Global Select Market under the symbol "DBVT."

    The ordinary shares are listed on Euronext Paris under the symbol "DBV."

    The settlement of the global offering and the admission of the new shares on the Nasdaq Global Select Market and Euronext Paris are expected to occur on 24 October 2014.

    Citigroup Global Markets Inc., Leerink Partners LLC and Bryan, Garnier & Co. are acting as joint global coordinators and joint book-running managers of the global offering. Citigroup Global Markets Inc. and Leerink Partners LLC are acting as representatives of the U.S. underwriters. Citigroup Global Markets Limited is acting as representative of the international underwriters. The U.S. underwriters are Citigroup Global Markets Inc, Leerink Partners LLC, Bryan, Garnier & Co and Trout Capital LLC.  The international underwriters are Citigroup Global Markets Limited and Bryan, Garnier & Co.

    Seite 1 von 3




    GlobeNewswire
    0 Follower
    Autor folgen

    Verfasst von GlobeNewswire
    DBV Technologies S.A. Announces Proposed Global Offering DBV Technologies S.A. Announces Proposed Global Offering Bagneux, France - October 20, 2014 - DBV Technologies (Euronext: DBV - ISIN: FR0010417345), a clinical-stage specialty biopharmaceutical company announced today that it intends to offer and …